Flank fat. Localized adiposity
Conditions
Interventions
Intervention group: patients aged 21-65 years with clinically proven mild to moderate flank fat and based on measurement with calipers and ultrasound criteria. Before the intervention, the patients ar
Sponsors
Espad Pharmed Co
Eligibility
Sex/Gender
All
Age
21 Years to 65 Years
Inclusion criteria
Inclusion criteria: Mild to moderate flank fat (clinically proven and based on caliper measurements and ultrasound criteria) Ability to complete the study and follow instructions Informed consent to participate in the study Consent on not performing any other intervention in the flank area during the study period
Exclusion criteria
Exclusion criteria: Severe medical or psychological conditions that interfere with the study results History of hypersensitivity to components of the product under study Pregnancy and breastfeeding History of previous flank fat treatment BMI >?? Patients prone to intravascular volume reduction Evidence of recent alcohol or drug abuse History of bleeding disorders or recent consumption (less than 3 weeks) of thrombolytic drugs, anticoagulants, platelet inhibitors orNSAIDs History of hypertrophic scarring Infection, inflammation, dermatosis, unhealed wound, cancer or precancerous lesions at the injection site
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of flank fat reduction. Timepoint: The beginning of the study and week 6 and 12. Method of measurement: Using ultrasound and calipers. | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence and seriousness of adverse event. Timepoint: week 6 and 12. Method of measurement: Examination by the medical team with a questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKamran Balighi
Tehran University of Medical Sciences
Outcome results
None listed